logo

Global Blood Therapeutics (GBT)



Trade GBT now with
  Date
  Headline
11/22/2022 7:34:46 PM Guerbet To Spotlight The Novel New Drug Elucirem Injection
9/7/2021 8:18:24 AM Global Blood Therapeutics: FDA Accepts Priority Review SNDA For Oxbryta For Sickle Cell Disease In Children Ages 4-11
3/18/2021 7:10:21 AM Global Blood Therapeutics Adds Alexis Thompson To Board
8/12/2019 7:59:46 AM Wedbush Is Lowering Global Blood Therapeutics (GBT) FY20 Estimate To -3.57 From -3.50
8/12/2019 7:59:13 AM Wedbush Is Lowering Global Blood Therapeutics (GBT) Q4 20 Estimate To -0.79 From -0.77
8/12/2019 7:58:00 AM Wedbush Is Lowering Global Blood Therapeutics (GBT) Q3 20 Estimate To -0.87 From -0.85
8/12/2019 7:57:37 AM Wedbush Is Cutting Global Blood Therapeutics (GBT) Q2 20 Estimate To -0.96 From -0.94
8/12/2019 7:57:27 AM Wedbush Is Lowering Global Blood Therapeutics (GBT) Q1 20 Estimate To -0.96 From -0.94
8/12/2019 7:57:12 AM Wedbush Is Lowering Global Blood Therapeutics (GBT) FY19 Estimate To -3.99 From -3.62
8/12/2019 7:56:57 AM Wedbush Is Cutting Global Blood Therapeutics (GBT) Q4 19 Estimate To -1.06 From -0.94
8/12/2019 7:56:46 AM Wedbush Is Lowering Global Blood Therapeutics (GBT) Q3 19 Estimate To -1.04 From -0.92
8/12/2019 7:55:00 AM Wedbush Reiterates Global Blood Therapeutics (GBT) At Outperform With $103 Price Target
6/17/2019 6:11:43 AM Wedbush Reiterates Global Blood Therapeutics (GBT) At Outperform With $107 Price Target
6/11/2019 3:27:41 PM Wedbush Is Lowering Global Blood Therapeutics (GBT) 2020 Estimate To -3.70 From 0.26
6/11/2019 3:27:25 PM Wedbush Is Cutting Global Blood Therapeutics (GBT) 4Q20 Estimate To -0.82 From 0.16
6/11/2019 3:27:13 PM Wedbush Is Lowering Global Blood Therapeutics (GBT) 3Q20 Estimate To -0.90 From 0.08
6/11/2019 3:26:56 PM Wedbush Is Cutting Global Blood Therapeutics (GBT) 2Q20 Estimate To -0.99 From 0.01
6/11/2019 3:26:45 PM Wedbush Is Lowering Global Blood Therapeutics (GBT) 1Q20 Estimate To -0.99 From 0.01